Longevity · Peptides · Precision Medicine · Healthy Aging
Advancing Healthy Aging Through Research, Education, and Personalized Longevity.
LII Longevity is the educational publication of Longevity Institute International. We help readers understand biomarkers, biological age, preventive medicine, emerging longevity therapies, and the foundational habits that support a longer healthspan — translated from research into language you can use in your next conversation with a healthcare professional.
Testing, therapies, and peptides are discussed throughout this publication — but eight foundational domains consistently shape long-term health outcomes in the research literature.
Resistance and cardiovascular training.
Balanced intake and adequate protein.
Consistent, sufficient sleep quality.
Blood sugar, lipids, and body composition.
Screenings and early risk identification.
Learning, memory, and mental engagement.
Relationships linked to long-term health.
Regulation of chronic physiological stress.
Four editorial pillars organize our coverage — from how biological age is measured to how established and emerging therapies are evaluated.
Biomarkers, epigenetic clocks, and functional measures — and what they can and cannot tell you.
Biological age estimates vary by methodology and lab, and do not provide a definitive prediction of lifespan or future health.
Explore Biological Age →A balanced look at NAD+, metformin, GLP-1 therapies, hormone optimization, and rapamycin research.
Evidence, approved indications, and regulatory status differ across these therapies — each is covered on its own terms.
Explore Longevity Therapies →What peptides are, which are approved medications, and which remain experimental compounds.
Most peptides discussed here have limited human evidence and are not approved for general use.
Explore Peptide Education →Nutrition, exercise, sleep, and stress management remain central to healthspan.
Foundational habits remain central regardless of interest in testing, medications, or peptides.
Explore Healthy Living →Selected articles translating current research into practical understanding. Headlines below are demonstration content for this template.
An editorial overview of how biological age estimates are calculated, why results can differ meaningfully between test types, and why context from a qualified healthcare professional matters more than any single number.
Read the Overview →Understand the Evidence Behind Biomarkers
Biomarkers in Personalized LongevityMetformin and Healthy Aging: Reading the Research Carefully
Longevity TherapiesPeptide Research: Established Uses vs. Experimental Claims
Peptide EducationWhy Strength Training Remains Central to Healthspan
Healthy LivingPersonalization in longevity medicine is a structured, clinically supervised process — not a single test or product. Testing and personalization require context, and do not guarantee outcomes.
Each stage involves a qualified healthcare professional. No stage of this process guarantees a specific health outcome.
Chronological age counts years lived. Biological age is an estimate — drawn from blood-based biomarkers, epigenetic clocks, metabolic indicators, and functional measures — of how the body appears to be aging. It is not a definitive forecast of lifespan, disease, or future health.
Biological Age Is an Estimate, Not a Verdict.
Chronological vs. Biological AgeEpigenetic Clocks Measure Different Things Differently.
Testing VariabilityA Result Means More With a Clinician in the Room.
Interpretation With Healthcare ProfessionalsA growing hub of educational coverage, organized by subject and by the questions readers ask most.
An estimate of how the body appears to be aging, based on biomarkers rather than years lived. Methods vary, and no single result should be treated as definitive.
Relevance depends on individual health history, symptoms, and goals. A qualified clinician can help prioritize which markers are meaningful for you.
Consider the methodology, validation data, and whether results are interpreted alongside your broader medical history rather than in isolation.
Ask what a result changes about your care plan, how confident the evidence is, and what risks or alternatives exist before starting anything new.
Established uses have regulatory approval and substantial human evidence. Experimental use means evidence is limited, preliminary, or drawn mainly from lab or animal research.
Nutrition, movement, sleep, and stress management are foundational and consistently supported by research on metabolic markers.
Resistance training, balance work, and adequate protein intake are consistently linked to preserved function with age.
Daily habits accumulate over decades and remain central to healthspan regardless of interest in testing or therapies.
Each therapy below is presented with its approved indications, current human evidence, known risks, and regulatory status. None are described as proven to extend lifespan.
Approved for type 2 diabetes management with decades of clinical use. Its potential role in general healthy aging is under active research but not an approved indication.
Approved for type 2 diabetes and, for some formulations, chronic weight management, with strong supporting clinical trial evidence for those indications.
Approved at higher doses for substance use disorders. Low-dose use for inflammatory or chronic-pain conditions is off-label, with a growing but still limited evidence base.
Proposed to support cellular energy metabolism. Human clinical evidence for anti-aging benefits remains limited, with most supportive data from preclinical research.
Studied extensively in animal models for lifespan extension via mTOR inhibition. Human longevity evidence is minimal; it is approved for specific unrelated medical indications.
Includes menopausal hormone therapy and testosterone therapy. Approved uses exist for diagnosed deficiency; use for general anti-aging purposes is not an approved indication.
Peptides are short chains of amino acids. A small number are approved medications; most discussed in longevity contexts are experimental compounds with limited human evidence and meaningful product-quality and contamination risks.
Studied in animal models for tissue repair. Not approved for human use in the United States; human clinical evidence is minimal.
A copper-binding peptide studied for skin and wound applications, largely in cosmetic and preclinical research contexts.
An approved growth-hormone-releasing hormone analog with historical use for specific diagnosed deficiencies, prescribed and monitored by a physician.
A growth-hormone-releasing hormone analog used off-label and through compounding pharmacies; long-term safety data in healthy adults is limited.
A growth-hormone secretagogue often paired with CJC-1295 in off-label protocols; evidence in healthy longevity contexts remains limited.
A mitochondrial-derived peptide studied for metabolic signaling, primarily in preclinical and mechanistic research.
Testing, therapies, medications, peptides, and supplements do not replace the fundamentals of health. Research consistently points back to these foundational habits.
Preserves strength and function.
Supports heart and metabolic health.
Including sufficient protein intake.
Foundational to recovery and health.
Assessed individually, not by ideal charts.
Chronic stress affects long-term health.
Support early identification of risk.
Linked to long-term wellbeing.
A single number rarely tells the full story. These factors shape how a biomarker result should be interpreted.
| Factor | Why It Matters |
|---|---|
| Reference Ranges | Ranges vary by lab, population, age, and sex — a value outside one lab's range may fall within another's. |
| Trends Over Time | A single measurement is a snapshot; repeated testing shows direction and stability. |
| Individual Context | Personal and family health history shapes how a result should be weighed. |
| Measurement Error | All lab testing carries some margin of error and day-to-day biological variation. |
| Laboratory Variation | Different labs and assay methods can produce different results for the same sample. |
| Medications | Prescription and over-the-counter medications can shift biomarker levels. |
| Symptoms | Lab values are interpreted alongside how a person actually feels and functions. |
| Lifestyle Factors | Recent sleep, exercise, illness, and diet can all temporarily affect results. |
| Clinical Interpretation | A qualified healthcare professional integrates all of the above — software and self-testing cannot substitute for this. |
LII Longevity's editorial coverage draws on perspectives from across medicine and allied health disciplines. Contributor profiles and credentials are confirmed prior to publication.
Grounded in current research and clinical guidelines.
Analysis reviewed by qualified professionals.
Coverage decisions are made independently of advertisers.
Sourced from peer-reviewed and clinical literature.
Written to support real conversations with clinicians.
Coverage is revisited as research evolves.
Context-aware education, not one-size-fits-all claims.
LII Longevity is the educational publication of Longevity Institute International. Its mission is to advance public understanding of healthy aging through research, education, and evidence-based medical insights.
Inspired by experience in personalized longevity medicine, the publication explores how biomarkers, biological age, supplements, peptides, physician-guided therapies, and healthy lifestyle strategies may fit within responsible approaches to healthspan.
LII Longevity is an educational publication and does not provide individualized medical care. For diagnosis, treatment, or personalized guidance, consult a qualified healthcare professional.
The future of longevity is built on scientific discovery, informed decision-making, and a lifelong commitment to better health.